Belgium vs Poland: 10_Insured export credit exposures, short term
Belgium
47.53 billion BU
in 2025
Poland
53.70 billion BU
in 2025
Belgium rank
13th
Poland rank
10th
10_Insured export credit exposures, short term over time
- Belgium
- Poland
How they compare
Poland currently reports 53.70 billion BU against 47.53 billion BU in Belgium, a difference of 6.17 billion BU.
That makes Poland's figure about 1.1 times Belgium's.
The two have swapped places 1 time across 21 shared years of data; in 2005 it was Belgium ahead.
Belgium ranks 13th and Poland ranks 10th of 210 countries.
Across the 3 decades both report, Belgium averaged higher in 2 and Poland in 1.
Head to head by decade
| Decade | Belgium | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.18 billion BU | 14.33 billion BU | 7.86 billion BU | Belgium |
| 2010s | 27.00 billion BU | 23.77 billion BU | 3.23 billion BU | Belgium |
| 2020s | 44.16 billion BU | 46.08 billion BU | 1.92 billion BU | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher 10_insured export credit exposures, short term, Belgium or Poland?
- Poland, at 53.70 billion BU against 47.53 billion BU in Belgium as of 2025.
- What is the difference in 10_insured export credit exposures, short term between Belgium and Poland?
- 6.17 billion BU, with Poland ahead.
- How many years of comparable data are there for Belgium and Poland?
- 21 years are reported by both, from 2005 to 2025.
- How do Belgium and Poland rank globally for 10_insured export credit exposures, short term?
- Belgium ranks 13th and Poland ranks 10th of 210 countries.
- Where does this data come from?
- BIS, published as 10_Insured export credit exposures, short term (BU). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
ST refers to insured export credits with credit terms up to and including 12 months, except for transactions involving an insured manufacturing (pre-credit) risk with a risk period of more than 12 months, which are classified as medium/long-term (MLT).